Somewhat Positive News Coverage Somewhat Unlikely to Affect Dolby Laboratories (DLB) Share Price

News articles about Dolby Laboratories (NYSE:DLB) have trended somewhat positive on Saturday, according to Accern. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Dolby Laboratories earned a news sentiment score of 0.19 on Accern’s scale. Accern also gave news coverage about the electronics maker an impact score of 46.3884797168961 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the media stories that may have impacted Accern Sentiment’s analysis:

Several equities research analysts recently weighed in on DLB shares. Zacks Investment Research raised shares of Dolby Laboratories from a “sell” rating to a “hold” rating in a research report on Tuesday, July 4th. BidaskClub raised shares of Dolby Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, July 8th. B. Riley raised shares of Dolby Laboratories from a “neutral” rating to a “buy” rating and raised their price target for the company from $57.00 to $61.50 in a research report on Monday, July 17th. Finally, Piper Jaffray Companies reissued a “hold” rating and set a $52.00 price target (up previously from $49.00) on shares of Dolby Laboratories in a research report on Wednesday, September 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the stock. Dolby Laboratories presently has a consensus rating of “Hold” and an average price target of $58.83.

Shares of Dolby Laboratories (NYSE DLB) opened at 59.36 on Friday. The company has a market cap of $6.09 billion, a P/E ratio of 30.36 and a beta of 0.85. Dolby Laboratories has a 12 month low of $44.99 and a 12 month high of $59.79. The company’s 50 day moving average is $55.54 and its 200 day moving average is $52.16.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Tuesday, July 25th. The electronics maker reported $0.75 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.10. Dolby Laboratories had a net margin of 19.02% and a return on equity of 10.25%. The business had revenue of $305.67 million for the quarter, compared to analyst estimates of $296.88 million. During the same quarter in the prior year, the business posted $0.62 EPS. Dolby Laboratories’s revenue for the quarter was up 10.1% compared to the same quarter last year. On average, equities research analysts predict that Dolby Laboratories will post $1.99 EPS for the current fiscal year.

In other Dolby Laboratories news, major shareholder Dagmar Dolby sold 100,000 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $52.22, for a total transaction of $5,222,000.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Mark Andrew Sherman sold 14,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $56.25, for a total transaction of $787,500.00. The disclosure for this sale can be found here. Insiders have sold a total of 1,419,000 shares of company stock worth $71,701,100 in the last 90 days. 43.80% of the stock is currently owned by company insiders.

ILLEGAL ACTIVITY WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Affect Dolby Laboratories (DLB) Share Price” was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/10/14/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-dolby-laboratories-dlb-share-price.html.

About Dolby Laboratories

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply